Skip to content

Clinical trials

Phase 3 Gastroesophageal Reflux trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 3 Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20033
20047
20059
200616
20074
20087
20097
20104
20114
20125
201310
20141
20151
20163
20171
20183
20211
20221
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Unknown status9
Withdrawn6
Terminated5
Recruiting2
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda13
AstraZeneca12
Wyeth is now a wholly owned subsidiary of Pfizer8
Eisai Inc.6
Reckitt Benckiser Healthcare (UK) Limited4
Ahn-Gook Pharmaceuticals Co.,Ltd2
Chinese University of Hong Kong2
Cinclus Pharma Holding AB2
Eurofarma Laboratorios S.A.2
Ironwood Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux103
Heartburn17
Dyspepsia6
Esophagitis, Peptic3
Peptic Ulcer3
Abdominal Pain2
Asthma2
Cough2
Disease2
Esophageal Diseases2

Trials

Showing 26 to 50 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.